Navigation Links
Ibrutinib has 'unprecedented' impact on mantle cell lymphoma
Date:12/14/2012

ATLANTA - An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side effects.

Researchers from The University of Texas MD Anderson Cancer Center presented interim findings of the multi-center Phase 2 study today at the 54th American Society of Hematology Annual Meeting and Exposition.

"I believe we are witnessing a breakthrough in mantle cell lymphoma. This is great news for patients," said Michael Wang, M.D., associate professor in MD Anderson's Departments of Lymphoma and Myeloma and Stem Cell Transplantation and Cellular Therapy. Wang is lead author of the study.

Wang, director of the mantle cell lymphoma (MCL) program at MD Anderson, has spent the past 12 years researching the disease, including clinical trials of proteasome inhibitors, immune-modulating agents and an mTOR inhibitor.

"In a heavily treated relapsed or refractory population, oral ibrutinib induced a response rate as high as 70 percent - better than any other single agent ever tested in MCL," he said. "The response is durable with a long progression-free survival. "

Dangerous disease presents treatment challenges

MCL is a rare and aggressive B-cell subtype of non-Hodgkin lymphoma that, according to the Leukemia and Lymphoma Society, accounts for 6 percent of non-Hodgkin cases. Despite high response rates to initial combination-drug chemotherapy, which is highly toxic, patients often relapse.

Bruton's tyrosine kinase is a mediator of B cell receptor signaling, which is essential for normal B-cell development. Ibrutinib inhibits Bruton's tyrosine kinase (BTK), causing cell death and decreasing cellular migration and adhesion in malignant B-cells.

"The foundation for this clinical success is based on biology," Wang said. "The B-cell receptor pathway is critical in B-cell lymphoma. BTK is the driver molecu
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Unprecedented accuracy in locating brain electrical activity with new device
3. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
4. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
5. Social ties have mixed impact on encouraging healthy behaviors in low-income areas
6. Pediatric epilepsy impacts sleep for the child and parents
7. Dartmouth researchers investigate the cognitive effects of athlete head impacts
8. Comprehensive report documents impact of urologic diseases on American public
9. New federal disclosure law may have little impact on drugs prescribed
10. After 25 years, World No Tobacco Day is making an impact
11. Sleep apnea persisting into teens can impact life skills, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ibrutinib has 'unprecedented' impact on mantle cell lymphoma
(Date:8/4/2015)... & LAS VEGAS (PRWEB) , ... August 04, 2015 , ... ... the pitch schedule for vendor participating in The ISE® Lions’ Den and Jungle Lounge ... Spa at Aria in Las Vegas. , During the event, eight emerging security vendors, ...
(Date:8/4/2015)... , ... August 04, 2015 ... ... HealthCenter personal health record (PHR) product has achieved Office of the National ... EHR Certification from Drummond Group. HealthCenter delivers the highest quality personal health ...
(Date:8/4/2015)... ... 04, 2015 , ... Updated enrollment data on the top U.S. health plans, ... accessed at http://www.AISHealth.com . The data is free to all registered users to ... and charts on the website’s “Data” section include:, , Top ...
(Date:8/4/2015)... ... 04, 2015 , ... Rock Your Hair, http://www.rockyourhair.com has signed on ... addition, they have signed Lexi Noel, dubbed the Teen Beauty Queen by her fans ... branding opportunities for the company. , The Pop & Rock Beauty Bash is ...
(Date:8/4/2015)... ... August 04, 2015 , ... The goal of looking younger – with ... invasive surgery to achieve this ideal is not. But minimally invasive procedures such as ... high cost or lengthy recovery time, according to Valerie Goldburt, MD, PhD , ...
Breaking Medicine News(10 mins):Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4
... Low serum adiponectin levels predict an increased future risk ... according to a new study. "Adiposity is known ... between adiponectin (a protein produced by adipose tissue) and ... humans has been conflicting," said lead author Akshay Sood, ...
... Mothers, exposure during pregnancy to a class of air ... problems in their children. PAH are,released to air during ... coal, and other,organic material. , The study is the ... problems among school‐age children and two complementary measures of ...
... HealthDay Reporter , WEDNESDAY, March 21 (HealthDay News) -- ... therapies such as acupuncture, acupressure and dietary changes may ... new pilot study suggests. The authors say that ... potential of combining Western medicine with Eastern therapies among ...
... By Maureen Salamon HealthDay Reporter , ... drug appears safe and effective in people already taking ... to statin therapy or an alternative, a preliminary new ... and a multiple-dose trial in a group with high ...
... such as Fosamax, Boniva and Actonel, may have a protective ... Ford Hospital. Endometrial cancer affects more than ... 60s, although it can occur before 40. A type of ... there is no known preventive medication for women at high ...
... 20, 2012) Ching-Hon Pui, M.D., a renowned leader in ... of the 2012 Pediatric Oncology Award from the American Society ... to better understanding the blood cancer,s biology and treatment as ... Pui will receive the award in June at the 2012 ...
Cached Medicine News:Health News:Low serum adiponectin levels predict future risk for asthma in women 2Health News:Prenatal exposure to combustion-related pollutants and anxiety, attention problems in young children 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 3Health News:Statin Alternative Looks Promising in Early Trials 2Health News:Statin Alternative Looks Promising in Early Trials 3Health News:Study: Low bone density medications may have protective effect on endometrial cancer 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 2Health News:ASCO honors Ching-Hon Pui, M.D., for work advancing childhood cancer research and treatment 3
(Date:8/4/2015)... -- Second Quarter 2015 Highlights: , ... of 2014 , Net earnings attributable to Team Health ... adjustments , Diluted net earnings per share of $0.39; ... to $99.4 million 2015 Outlook: , ... 24.0% to 26.0%; Adjusted EBITDA margin remains between 10.5% and ...
(Date:8/4/2015)... Aug. 4, 2015 Among 1,000 U.S. consumers, ... only half of consumers surveyed are aware of prescription ... used use them, according to findings from a new ... service partnership focused on improving the health and well-being ... survey polled 1,000 men and women, ages 21 and ...
(Date:8/4/2015)... Wis. , Aug. 4, 2015  Ironshore ... agreement with Restore Health, a company specializing in ... a double-blind clinical trial, designed to evaluate the ... in development to treat Attention-deficit/hyperactivity disorder (ADHD). This ... Restore Health originally partnered with Ironshore ...
Breaking Medicine Technology:Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 2Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 3Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 4Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 5Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 6Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 7Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 8Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 9Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 10Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 11Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 12Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 13Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 14Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 15Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 16Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 17Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 18Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 19Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 20Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 21Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 22Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 23Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 24Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 25Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 26Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 27Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 28Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 29Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 30Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 31Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 32Team Health Holdings, Inc. Announces Second Quarter 2015 Financial Results 33New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... Nov. 1, 2011 Joseph F. Finn, Jr., C.P.A. ("Finn"), ... ("Epix"), announced today that the back-up compounds and S1P1 lead ... be offered December 8, 2011 in a sealed bid sale. ... total of 640 analogs were synthesized by Epix and/or Amgen ...
... Champions Oncology, Inc.  ("Champions" or  the "Company") (OTC ... engaged in the development of advanced technology solutions and ... drugs, has appointed Gary G. Gemignani to the Company,s ... Officer. Joel Ackerman, the Company,s Chief Executive Officer, served ...
Cached Medicine Technology:Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale 2Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 2Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: